Table 1.
Baseline Study and Patient Characteristics
| Patients Characteristics at Baseline | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total | Age | Ischemic | Antiplatelet | ||||||||
| Study | Patients, | Device | Follow‐Up | (Years) | Female | White | Diabetes | HTN | Stroke | TIA | Agents |
| (Ref. No.) | n | Type | Duration | (mean ± SD) | (%) | (%) | (%) | (%) | (%) | (%) | Use (%) |
| Gladstone, 2014 16 | I:286 | 30‐day noninvasive ambulatory ECG monitor | 3 months | I:72.5 ± 8.5 | I:46.2 | I:89.9 | I:19.2 | I:71.3 | I:65.7 | I:34.3 | na |
| C:285 | C:73.2 ± 8.8 | C:43.9 | C:91.2 | C:19.3 | C:67.0 | C:60.4 | C:39.6 | ||||
| Higgins, 2013 14 | I:50 | 7‐day non‐invasive cardiac event monitor | 14 days and 3 months | I:67.1 ± 11.1 | I:52 | na | I:8 | I:56 | I:70 | I:30 | I:72 |
| C:50 | C:64.6 ± 13.3 | C:36 | C:22 | C:60 | C:66 | C:34 | C:78 | ||||
| Kamel, 2013 17 | I:20 | 21‐day mobile cardiac | 3 and 12 months | I:65 ± 12 | I:40 | Na | I:20 | I:75 | I:60 | I:40 | I:na |
| C:20 | Outpatient telemetry | C:69 ± 9 | C:45 | C:30 | C:70 | C:75 | C:25 | C:na | |||
| Sanna, 2014 15 | I:221 | Insertable cardiac monitor | 6 and 12 months | I:61.6 ± 11.4 | I:35.7 | I:87.8 | I:15.4 | I:65.2 | I:90.5 | I:9.5 | I:95.9 |
| C:220 | C:61.4 ± 11.3 | C:37.3 | C:86.8 | C:17.3 | C:57.7 | C:91.4 | C:8.6 | C:96.4 | |||